July « 2014 « Science and Enterprise

Arcadia Awarded U.S. Patent for Longer Shelf-Life Tomato

By Alan, on July 17th, 2014%

(A. Kotok)

17 July 2014. Arcadia Biosciences, an agricultural biotechnology company in Davis, California received a patent for its engineered tomato that ripens slower after harvesting. Patent number 8,772,606, “Non-transgenic tomato varieties having increased shelf life post-harvest,” was awarded by the U.S. Patent and Trademark Office on 8 July to two inventors and assigned . . . → Read More: Arcadia Awarded U.S. Patent for Longer Shelf-Life Tomato

Food Safety Test Systems Company Raises $60 Million in IPO

By Alan, on July 17th, 2014%

(A. Kotok)

17 July 2014. Roka Bioscience Inc., a developer of molecular-level food safety tests in Warren, New Jersey, issued 5 million shares in its initial public offering (IPO) yesterday. The company priced the shares at $12.00, raising $60 million. Roka Bioscience will trade on the Nasdaq exchange under the symbol ROKA.

The company . . . → Read More: Food Safety Test Systems Company Raises $60 Million in IPO

Immunocore, Lilly Collaborate on T-Cell Cancer Therapies

By Alan, on July 16th, 2014%

T-cell (NIAID/NIH)

16 July 2014. Drug maker Eli Lilly and Company in Indianapolis and Immunocore Ltd., a biotechnology company in Oxford, U.K. are jointly discovering new cancer therapies based on T-cells in the body’s immune system. The deal will pay Immunocore $15 million for each new therapy identified, with additional payments of $10 . . . → Read More: Immunocore, Lilly Collaborate on T-Cell Cancer Therapies

Geisinger, Indivumed Partner on Personalized Cancer Therapy

By Alan, on July 15th, 2014%

(HealthyPeople.gov)

15 July 2014. Geisinger Health System that serves central and eastern Pennsylvania is partnering with Indivumed GmbH, a biotech company and biobank in Hamburg, Germany to provide individualized cancer diagnostics for Geisinger clients. Financial details of the deal first announced in May 2013, but formalized this week, were not disclosed.

Indivumed maintains . . . → Read More: Geisinger, Indivumed Partner on Personalized Cancer Therapy

Novartis Licensing Smart Lens Technology from Google

By Alan, on July 15th, 2014%

Smart lens (Google)

15 July 2014. The Alcon division of pharmaceutical company Novartis is licensing the rights to Google’s so-called smart lens technology for medical applications involving the eyes. Financial terms of the licensing agreement between Alcon that develops vision care products for Novartis and Google[x], part of the company’s research labs, were . . . → Read More: Novartis Licensing Smart Lens Technology from Google

Foam/Wax Material Adapted for Shape-Changing Robotics

By Alan, on July 14th, 2014%

Anette Hosoi (Arthur Petron, MIT)

14 July 2014. Engineers at Massachusetts Institute of Technology developed a process for combining foam and wax materials into components that allow robot devices to become pliable for changing their shape, yet return to a rigid state when needed to do their tasks. The team from the lab . . . → Read More: Foam/Wax Material Adapted for Shape-Changing Robotics

Chip Device Developed to Quickly Test for Type 1 Diabetes

By Alan, on July 14th, 2014%

Brian Feldman holds chip device for type 1 diabetes testing (Norbert von der Groeben, Stanford University)

14 July 2014. Medical researchers at Stanford University in California invented a small, handheld microchip that more quickly and easily tests for type 1 diabetes than current methods. The team led by Stanford pediatric endocrinologist Brian Feldman . . . → Read More: Chip Device Developed to Quickly Test for Type 1 Diabetes

Text Messages Help Young Adults Reduce Binge Drinking

By Alan, on July 11th, 2014%

(Highway Patrol Images/Flickr)

11 July 2014. Medical researchers at University of Pittsburgh show mobile phone text messages can provide feedback to young adults with a history of alcohol abuse that cuts their binge drinking. Findings from the team led by emergency medicine professor Brian Suffoletto were published online earlier this week in the journal . . . → Read More: Text Messages Help Young Adults Reduce Binge Drinking

Dengue Vaccine Shown to Cut Infections, Hospitalizations

By Alan, on July 11th, 2014%

Aedes aegypti mosquito that carries Dengue fever (CDC.gov)

11 July 2014. A large-scale clinical trial of a vaccine by the pharmaceutical company Sanofi shows the vaccine prevents symptomatic dengue cases by more than half, with severe forms and hospitalizations from the disease reduced even further. Findings from the study, conducted among more than . . . → Read More: Dengue Vaccine Shown to Cut Infections, Hospitalizations

Baxter Acquires Sickle-Cell Prevention Drug Developer

By Alan, on July 10th, 2014%

Red blood cells with sickle cell disease (NIH.gov)

10 July 2014. Baxter International in Deerfield, Illinois is acquiring AesRx LLC, a biopharmaceutical company in Newton, Massachusetts developing drugs for sickle-cell and other rare diseases. Baxter is making an initial payment to AesRx, which will be eligible for future payments tied to development and commercial . . . → Read More: Baxter Acquires Sickle-Cell Prevention Drug Developer

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise